ERBB2 and breast carcinoma: Therefore, liposomal emodin, both uncoated and coated with silk fibroin, was developed in order to increase its solubility and its effectiveness on Her2/neu over-expressing breast cancer cells BT-474 and MDA-MB-453 which is seen in 30% of breast cancer cells.